Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
March 04, 2024 16:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2023 Full Year Financial Results
March 04, 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
February 22, 2024 16:15 ET
|
Stereotaxis, Inc.
Intermountain Medical Center becomes the first hospital in the Intermountain region and in Utah to adopt the latest in robotic heart care technology.
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 20, 2024 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
January 08, 2024 08:34 ET
|
Stereotaxis, Inc.
Stereotaxis announces first patients treated using new Magnetic Interventional Catheter, MAGiC
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
November 28, 2023 08:42 ET
|
Stereotaxis, Inc.
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
November 20, 2023 08:54 ET
|
Stereotaxis, Inc.
Stereotaxis Chairman and CEO, David Fischel, will again participate in the Piper Sandler Healthcare Conference.
Stereotaxis Reports 2023 Third Quarter Financial Results
November 09, 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
October 31, 2023 08:57 ET
|
Stereotaxis, Inc.
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
October 17, 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...